LSL Pharma Group (TSXV:LSL) Total Liabilities : C$17.59 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Total Liabilities?

LSL Pharma Group's Total Liabilities for the quarter that ended in Sep. 2024 was C$17.59 Mil.

LSL Pharma Group's quarterly Total Liabilities declined from Mar. 2024 (C$18.31 Mil) to Jun. 2024 (C$17.48 Mil) but then increased from Jun. 2024 (C$17.48 Mil) to Sep. 2024 (C$17.59 Mil).

LSL Pharma Group's annual Total Liabilities increased from Dec. 2021 (C$17.92 Mil) to Dec. 2022 (C$22.02 Mil) and increased from Dec. 2022 (C$22.02 Mil) to Dec. 2023 (C$22.25 Mil).

LSL Pharma Group Total Liabilities Historical Data

The historical data trend for LSL Pharma Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Total Liabilities Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

Total Liabilities

16.31

17.92

22.02

22.25

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial										19.90	22.25	18.31	17.48	17.59

LSL Pharma Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LSL Pharma Group's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15.074	+	(7.171	+	8.8817841970013E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	22.25

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	30.9	-	8.655
	=	22.25

LSL Pharma Group's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.463	+	(9.091	+	1.2490009027033E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0.033	+	0	+	0)
	=	17.59

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	37.956	-	20.369
	=	17.59

LSL Pharma Group Total Liabilities Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

540 d’Avaugour Street, Suite 1800, Boucherville, QC, CAN, J4B 0G6

Website

https://www.laboratoirelsl.com

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines